Slovensko - slovenčina - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

norbrook laboratories (ireland) limited, Írsko - sol.

Slovensko - slovenčina - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

norbrook laboratories (ireland) limited, Írsko, - sol.

Slovensko - slovenčina - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

norbrook laboratories (ireland) ltd., Írsko - plv.sol.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

vitabalans oy, fínsko - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica

Európska únia - slovenčina - EMA (European Medicines Agency)

actavis group ptc ehf - topotekan - uterine cervical neoplasms; small cell lung carcinoma - antineoplastické činidlá - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. topotecan v kombinácii s cisplatin je indikovaný u pacientov s karcinóm krčka maternice opakujúce sa po rádioterapii a pre pacientov s Štádium ivb ochorenia. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.

Európska únia - slovenčina - EMA (European Medicines Agency)

astrazeneca ab - osimertinib mesilate - karcinóm, pľúc bez malých buniek - iné antineoplastické činidlá, protein kinase inhibítory - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cardiac science corporation 3303 monte villa parkway 98021 bothel, wa spojené štáty americké -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

anita dr. helbig, gmbh grafenstrasse 23 83098 brannenburg nemecko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

thuasne s.a. 120, rue marius aufan-bp 243 923 07 levallois-perret francúzsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

andreas fahl medizintechnik-vertrieb gmbh august-horch-strasse 4a 51149 köln nemecko -